Coronavirus envelope protein: a small membrane protein with multiple functions

Coronavirus envelope protein is a small membrane protein and minor component of the virus particles. It plays important roles in virion assembly and morphogenesis, alteration of the membrane permeability of host cells and virus-host cell interaction. Here we review recent progress in characterization of the biochemical properties, membrane topology and functions of the protein.

Biochemical evidence for the presence of mixed membrane topologies of the severe acute respiratory syndrome coronavirus envelope protein expressed in mammalian cells

Coronavirus envelope (E) protein is a small integral membrane protein with multi‐functions in virion assembly, morphogenesis and virus–host interaction. Different coronavirus E proteins share striking similarities in biochemical properties and biological functions, but seem to adopt distinct membrane topology. In this report, we study the membrane topology of the SARS‐CoV E protein by immunofluorescent staining of cells differentially permeabilized with detergents and proteinase K protection assay. It was revealed that both the N‐ and C‐termini of the SARS‐CoV E protein are exposed to the cytoplasmic side of the membranes (N_cytoC_cyto). In contrast, parallel experiments showed that the E protein from infectious bronchitis virus (IBV) spanned the membranes once, with the N‐terminus exposed luminally and the C‐terminus exposed cytoplasmically (N_exo(lum)C_cyto). Intriguingly, a minor proportion of the SARS‐CoV E protein was found to be modified by N‐linked glycosylation on Asn 66 and inserted into the membranes once with the C‐terminus exposed to the luminal side. The presence of two distinct membrane topologies of the SARS‐CoV E protein may provide a useful clue to the pathogenesis of SARS‐CoV.

Biochemical and functional characterization of the membrane association and membrane permeabilizing activity of the severe acute respiratory syndrome coronavirus envelope protein

A diverse group of cytolytic animal viruses encodes small, hydrophobic proteins to modify host cell membrane permeability to ions and small molecules during their infection cycles. In this study, we show that expression of the SARS-CoV E protein in mammalian cells alters the membrane permeability of these cells. Immunofluorescent staining and cell fractionation studies demonstrate that this protein is an integral membrane protein. It is mainly localized to the ER and the Golgi apparatus. The protein can be translocated to the cell surface and is partially associated with lipid rafts. Further biochemical characterization of the protein reveals that it is posttranslationally modified by palmitoylation on all three cysteine residues. Systematic mutagenesis studies confirm that the membrane permeabilizing activity of the SARS-CoV E protein is associated with its transmembrane domain.

Optical modulation and detection in slotted Silicon waveguides

We demonstrate a novel mechanism for low power optical detection and modulation in a slotted waveguide geometry filled with nonlinear electro-optic polymers. The nanoscale confinement of the optical mode, combined with its close proximity to electrical contacts, enables the direct conversion of optical energy to electrical energy, without external bias, via optical rectification, and also enhances electro-optic modulation. We demonstrate this process for power levels in the sub-milliwatt regime, as compared to the kilowatt regime in which optical nonlinear effects are typically observed at short length scales. Our results suggest that a new class of detectors based on nonlinear optics may be practical.

Expression of SARS-coronavirus envelope protein in Escherichia coli cells alters membrane permeability

To promote viral entry, replication, release, and spread to neighboring cells, many cytolytic animal viruses encode proteins responsible for modification of host cell membrane permeability and for formation of ion channels in host cell membranes during their life cycles. In this study, we show that the envelope (E) protein of severe acute respiratory syndrome-associated coronavirus can induce membrane permeability changes when expressed in Escherichia coli. E protein expressed in bacterial and mammalian cells under reducing conditions existed as monomers, but formed homodimer and homotrimer under non-reducing conditions. Site-directed mutagenesis studies revealed that two cysteine residues of the E protein were essential for oligomerization, leading to induction of membrane permeability. This is the first report demonstrating that a coronavirus-encoded protein could modify membrane permeability in E. coli cells.

Comments on “Bubble motion in aqueous surfactant solutions”

The numerical simulations of bubble motion in dilute surfactant solutions reported previously by two of the authors contained a serious numerical inaccuracy. In agreement with experiments, single bubbles released from rest were predicted to reach a maximum speed before slowing to a terminal speed. However, subsequent experiments demonstrated that, in the simulations, the bubbles reached their terminal speed too quickly. The source of the discrepancy is an inaccuracy associated with the numerical algorithm used to solve the surfactant transport equation on the bubble surface. After correcting the problem, the simulations agree much better with the experiments.

Myosin-induced autoimmune myocarditis in BALB/C mice

Experimental mice were immunized with cardiac myosin and complete Freund's adjuvant (CFA) on days 0, 7 and 30 and control mice were immunized with CFA. Sera and myocardium samples were harvested on days 15, 21 and 120 after the first immunization. Pathological findings demonstrated that there were necrosis and inflammatory infiltration in acute stage and fibrosis mainly in chronic stage of experimental group. Anti-myosin antibodies were also found in sera of experimental mice, but not in control group. Our study showed that cardiac myosin served as an autoantigen to provoke autoimmunity and lead to the transformation of VMC into DCM.

[Determination of shrinkage and bending strength of GI-II infiltrated ceramic]

OBJECTIVE

To determine the shrinkage and strength of GI-II Infiltrated Ceramic for providing scientific basis of its clinical use.

METHODS

The adobes by slip-casting alumina powder of GI-II Infiltrated Ceramic were sintered at 1125 degrees C for 2 hours. The sintered alumina bodies were then divided into two groups and infiltrated by melt glass at 1125 degrees C and 1100 degrees C respectively for 6 hours. The length of the infiltrated ceramic specimens before and after fabrication was determined to calculate shrinkage. Their strength values were obtained by 3-point bending test.

RESULTS

The infiltrated ceramic infiltrated at 1125 degrees C was 0.289 +/- 0.155% in shrinkage, 367.7 +/- 76.1 MPa in strength, and 4.79 in Weibull modulus; that infiltrated at 1100 degrees C was 0.253 +/- 0.043%, 377.5 +/- 64.4 MPa, and 5.52, respectively. There was no statistically significant difference between those two groups. But their strength values were statistically high, compared with 300 MPa.

CONCLUSION

The shrinkage of GI-II Infiltrated Ceramic could be compensated by brushing spacer on dies and expansion of die stone. Its strength satisfied the requirement for clinical use of all-ceramic bridge materials. This kind of high-strength and low-shrinkage ceramic could be used for fabricating all ceramic crown and bridge core.

[The influences of crystallized compositions in the porcelain on bonding strength of titanium to porcelain]

OBJECTIVE

Sufficient porcelain-titanium bond is a vital factor determining the clinical performance of titanium-porcelain restorations. The purpose of this study was to investigate the effects of self-preparation La-porcelain composition on the porcelain-titanium bonding strength and to compare with the Vita Titankeramik.

METHODS

The present study examines 5 different recipes of porcelain by weight%: SiO2, 12%-17%; LaO2, 7%-10%; Al2O3, 9%-14%; B2O3, 23%-31%; CaO, 6%-8%; K2O, 2%-3%; SrO, 2%-4%; Na2O, 1%-3%; SnO2, 8%-10%; ZrO2, 3%-5%; TiO2, 6%-8%. Specimens were tested in push type shear with a universal testing machine. Scanning electron microscopy (SEM) and electron probe microanalyzer (EPMA) were employed to reveal the microstructures and diffusion of elements in the interfacial regions between the porcelain coating and titanium to the bond strength when fired at 800 degrees C.

RESULTS

The ratios of crystallized compositions had significant influences on the porcelain-titanium bond strength (P < 0.05). La-porcelain had the highest shear bond strength (37.76 MPa). The shear bond strength of the Vita Titankeramik to titanium was 20.18 MPa. The results of SEM revealed integrity of porcelain-titanium joints in La-porcelain and a greater amount of porosity in the interface of Vita Titankeramik to titanium. EPMA analysis demonstrated the aggregation of Si and Sn in the interfacial regions and their diffusion into the titanium.

CONCLUSION

Chemical compositions of porcelain and ratios of crystallized compositions play the important role in the titanium porcelain bond. La-porcelain had the highest shear bond strength and good porcelain-titanium joints. La-porcelain is a new-style low fusing porcelain/titanium system.

Coronary angiographic findings in African-American and white patients from a single institution

No data exist comparing clinical and angiographic findings in large numbers of contemporary African-American and white patients from the same hospital. Limited angiographic data on African Americans were obtained from hospitals serving predominantly minority patients, making the valid African-American:white comparisons difficult. The study included 2,624 consecutive white and 1,793 African-American patients who had angiography for diagnostic evaluation of presumed coronary artery disease at the Louisiana State University Medical Center in Shreveport between 1990 and 1997. Compared to whites of the same sex, a greater proportion of African-American patients had a history of hypertension, stroke, and heart failure. African Americans also had significantly higher systemic and left ventricular pressure, lower ejection fraction, greater echocardiographic left ventricular mass index, and more concentric hypertrophy. The overall proportion of patients with normal or minimal stenosis of coronary artery (<50% narrowing in the luminal diameter) was greater in African Americans than in whites for both men and women. This difference was predominately found in men aged > or = 55 years or older. Except among older men, African-American patients with coronary heart disease had a similar distribution of 1-, 2-, 3-vessel disease and mean stenosis score compared to whites. In conclusion, a higher frequency of normal coronaries and less frequent coronary stenosis were found in older African-American men. The African-American:white differences in angiographic findings were minimal in younger men and in women. However, African Americans had worse clinical profiles than whites.

Locating acoustic emission with an amplitude-multiplexed acoustic sensor array based on a modified mach-zehnder interferometer

We report on an amplitude-division-multiplexed interferometric sensor array for locating acoustic emission. Preliminary experiments were carried out with a modified Mach-Zehnder interferometer consisting of two sensing arms and a reference arm and demonstrated a one-dimensional location accuracy of a few centimeters. The system can be extended for two- and three-dimensional location of acoustic emissions by the addition of one or two more sensing arms, respectively, in the interferometer.

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

Cardiac hypertrophy is a major cause of morbidity and mortality worldwide. The hypertrophic process is mediated, in part, by small G proteins of the Rho family. We hypothesized that statins, inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase, inhibit cardiac hypertrophy by blocking Rho isoprenylation. We treated neonatal rat cardiac myocytes with angiotensin II (AngII) with and without simvastatin (Sim) and found that Sim decreased AngII-induced protein content, [3H] leucine uptake, and atrial natriuretic factor (ANF) promoter activity. These effects were associated with decreases in cell size, membrane Rho activity, superoxide anion (O2*-) production, and intracellular oxidation, and were reversed with L-mevalonate or geranylgeranylpyrophosphate, but not with farnesylpyrophosphate or cholesterol. Treatments with the Rho inhibitor C3 exotoxin and with cell-permeable superoxide dismutase also decreased AngII-induced O2*- production and myocyte hypertrophy. Overexpression of the dominant-negative Rho mutant N17Rac1 completely inhibited AngII-induced intracellular oxidation and ANF promoter activity, while N19RhoA partially inhibited it, and N17Cdc42 had no effect. Indeed, Sim inhibited cardiac hypertrophy and decreased myocardial Rac1 activity and O2*- production in rats treated with AngII infusion or subjected to transaortic constriction. These findings suggest that statins prevent the development of cardiac hypertrophy through an antioxidant mechanism involving inhibition of Rac1.